Diagnostic Performance of

18F-FDG PET/CT diagnostic performance infectious diseases infectious endocarditis meta-analysis native valve endocarditis positron emission tomography systematic review.

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
25 Sep 2020
Historique:
received: 18 08 2020
revised: 22 09 2020
accepted: 23 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

Infectious endocarditis is a life-threatening disease, requiring prompt and accurate diagnosis. The aim of this article is to perform a systematic review and meta-analysis of the literature to estimate the performance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ( Selected articles evaluating the diagnostic accuracy of Seven studies (351 episodes of suspected NVE) were included. In our systematic review and meta-analysis,

Sections du résumé

BACKGROUND BACKGROUND
Infectious endocarditis is a life-threatening disease, requiring prompt and accurate diagnosis. The aim of this article is to perform a systematic review and meta-analysis of the literature to estimate the performance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (
METHODS METHODS
Selected articles evaluating the diagnostic accuracy of
RESULTS RESULTS
Seven studies (351 episodes of suspected NVE) were included.
CONCLUSIONS CONCLUSIONS
In our systematic review and meta-analysis,

Identifiants

pubmed: 32993032
pii: diagnostics10100754
doi: 10.3390/diagnostics10100754
pmc: PMC7601576
pii:
doi:

Types de publication

Journal Article

Langues

eng

Commentaires et corrections

Type : CommentIn

Références

Am Heart J. 1997 Oct;134(4):656-64
pubmed: 9351732
J Am Coll Cardiol. 2013 Jun 11;61(23):2374-82
pubmed: 23583251
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Rev Port Cardiol (Engl Ed). 2019 Aug;38(8):573-580
pubmed: 31679647
Nat Rev Dis Primers. 2016 Sep 01;2:16059
pubmed: 27582414
Nucl Med Commun. 2018 Aug;39(8):747-752
pubmed: 29762262
J Nucl Cardiol. 2020 Apr;27(2):592-608
pubmed: 30066279
J Am Coll Cardiol. 1999 Jun;33(7):2023-9
pubmed: 10362209
Clin Infect Dis. 2020 Feb 3;70(4):583-594
pubmed: 30949690
Medicine (Baltimore). 2014 Dec;93(27):e237
pubmed: 25501088
J Nucl Cardiol. 2019 Jun;26(3):922-935
pubmed: 29086386
Contrast Media Mol Imaging. 2019 Jul 25;2019:3018349
pubmed: 31427907
Circ Cardiovasc Imaging. 2020 Jun;13(6):e010600
pubmed: 32507019
J Nucl Med. 2011 Nov;52(11):1673-8
pubmed: 21984799
J Nucl Cardiol. 2020 Jun;27(3):849-861
pubmed: 31236832
JAMA. 2018 Jan 23;319(4):388-396
pubmed: 29362800
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
J Nucl Med. 2016 Nov;57(11):1726-1732
pubmed: 27261514
J Nucl Cardiol. 2017 Feb;24(1):86-99
pubmed: 27277502
JACC Cardiovasc Imaging. 2016 Dec;9(12):1462-1465
pubmed: 27344422
J Nucl Cardiol. 2022 Feb;29(1):158-165
pubmed: 32180137
Lancet Infect Dis. 2017 Jan;17(1):e1-e14
pubmed: 27746163
Glob Heart. 2014 Mar;9(1):131-43
pubmed: 25432123
Eur Heart J Cardiovasc Imaging. 2015 Nov;16(11):1223
pubmed: 26206465
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Clin Radiol. 2015 Jul;70(7):787-800
pubmed: 25917543
JACC Cardiovasc Imaging. 2018 Dec;11(12):1920-1922
pubmed: 30121263
Br Med J. 1885 Mar 14;1(1263):522-6
pubmed: 20751196

Auteurs

Christel H Kamani (CH)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Gilles Allenbach (G)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Mario Jreige (M)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Anna G Pavon (AG)

Department of Cardiology, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Marie Meyer (M)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Nathalie Testart (N)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Maria Firsova (M)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Victor Fernandes Vieira (V)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Sarah Boughdad (S)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Marie Nicod Lalonde (M)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Niklaus Schaefer (N)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.
University of Lausanne, CH-1011 Lausanne, Switzerland.

Benoit Guery (B)

University of Lausanne, CH-1011 Lausanne, Switzerland.
Department of Infectious Diseases, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Pierre Monney (P)

Department of Cardiology, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.
University of Lausanne, CH-1011 Lausanne, Switzerland.

John O Prior (JO)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.
University of Lausanne, CH-1011 Lausanne, Switzerland.

Giorgio Treglia (G)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.
University of Lausanne, CH-1011 Lausanne, Switzerland.
Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, CH-6500 Bellinzona, Switzerland.
Health Technology Assessment Unit, Academic Education, Research and Innovation Area, Ente Ospedaliero Cantonale, CH-6500 Bellinzona, Switzerland.

Classifications MeSH